Hydrogen
In clinical developmentAlso known as Dihydrogen, Molecular hydrogen, Protium.
Recent clinical, regulatory, research and industry developments relating to this drug.
New models shed light on how an exotic phase of hydrogen in Earth's core may behave
Hydrogen supply chains across Chinese provinces for production and transportation
Hydrogen's Feasibility and Safety as a Therapy in Extracorporeal Cardiopulmonary Resuscitation
Pilot Study of the Neuroprotective Effects of Hydrogen and Minocycline in Acute Ischemic Stroke
Direct Photocatalyzed Hydrogen Atom Transfer (HAT) for Aliphatic C-H Bonds Elaboration.
Single-Atom Catalysts: A Sustainable Pathway for the Advanced Catalytic Applications.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes3
Journals, researchers & institutions
- Chemical reviews2
- Small (Weinheim an der Bergstrasse, Germany)1
- Capaldo L1
- Daw P1
- Fagnoni M1
- Fornasiero P1
- Gaikwad RP1
- Gawande MB1
- Kumar A1
- Milstein D1
- Centre for Converging Technologies1
- CICECO-Aveiro Institute of Materials1
- Indian Institute of Science Education and Research Berhampur1
- Institute of Chemical Technology1
- Nanotechnology Centre1
- Regional Centre of Advanced Technologies and Materials1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials